Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. Doctors performing certain medical scans on ...

The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity. GLP-1 drugs are medications that mimic the natural hormone glucagon-like peptide ...

The global economy is weathering Donald Trump’s trade tariffs better than expected as activity gets a boost from strong investment in artificial intelligence and supportive fiscal and monetary ...

Share on Pinterest The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy New guidelines from the World Health Organization (WHO) ...

The World Health Organization issued new guidelines Monday recommending the use of GLP-1 drugs for treating obesity. In the new guidelines, the United Nations health agency made two key ...

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the way the U.N. agency has historically framed obesity treatment. The WHO ...

The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the condition, which ...

The popularity of GLP-1 weight-loss medications continues to soar—and their uptake is helping to push down obesity rates on a national scale—but a safe, evidence-based way off the drugs isn’t yet in ...

Drugmaker Eli Lilly is rolling out a new model to make it easier for employers to provide access to its GLP-1 drugs for weight management. Lilly said in an announcement that the model is built on ...

NORTH CAROLINA (WTVD) -- Scammers continue to target people on social media who want to lose weight. The popularity of GLP-1 weight loss drugs has exploded this past year, and so have the scams.

Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...